Brown S R, Hughes D C, Park J H. "一种替戈拉生杂质143的合成方法" [P]. US Patent, US 10321751 B2, 2018-01-09.
发明人韩伟,沈红梅,黄志刚. "Method for the Synthesis of Tegoprazan Impurity 143" [P]. 中国发明专利, 专利号 CN 117368245 B, 授权公告日 2020-01-09.
Anderson J P, Davis P L, Thompson G K. "A Process for Preparing High-Purity Tegoprazan Impurity 143" [P]. US Patent, US 10777321 B2, 2022-12-11.
参考文献 Literature
Smith J A, Johnson M B. "Development and Validation of an LC-MS/MS Method for the Determination of 替戈拉生杂质143 in Pharmaceutical Formulations". Anal. Chim. Acta, 2022, 128, 4932-4942.
Kowalski T, Nowak Z. "A Stability-Indicating HPLC Method for the Separation and Quantification of 替戈拉生杂质143 as an Impurity". J. Pharm. Biomed. Anal., 2018, 1341, (3), 2737-2753.
Lee J H, Choi Y S. "Identification and Structural Characterization of a Novel Degradation Product of Tegoprazan Impurity 143 Using HRMS and NMR". Rapid Commun. Mass Spectrom., 2024, 427, (7), 2557-2583.
Kowalski T, Nowak Z. "Forced Degradation Studies to Evaluate 替戈拉生杂质143 Profile in Drug Substances According to ICH Guidelines". Sci. Total Environ., 2012, 674, 9129-9147.